BlackRock Portfolio holdings
AUM
$5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+10.7%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$2.69T
AUM Growth
+$204B
(+8.2%)
Cap. Flow
+$492M
Cap. Flow
% of AUM
0.02%
Top 10 Holdings %
Top 10 Hldgs %
19.5%
Holding
5,172
New
192
Increased
1,726
Reduced
2,546
Closed
177
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$2.37B |
| 2 |
Zoom
ZM
|
+$1.88B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.5B |
| 4 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$1.43B |
| 5 |
SPDR Bloomberg High Yield Bond ETF
JNK
|
+$1.24B |
Top Sells
| 1 |
Apple
AAPL
|
+$3.71B |
| 2 |
Microsoft
MSFT
|
+$1.21B |
| 3 |
IAC Inc
IAC
|
+$1.2B |
| 4 |
Amazon
AMZN
|
+$809M |
| 5 |
Meta Platforms (Facebook)
META
|
+$765M |
Sector Composition
| 1 | Technology | 22.69% |
| 2 | Healthcare | 14.52% |
| 3 | Consumer Discretionary | 12.01% |
| 4 | Financials | 11.66% |
| 5 | Communication Services | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PFSW
3326
DELISTED
PFSweb, Inc.
PFSW
| $6.73M | ﹤0.01% |
1,005,519
-13,265
| -1% | -$88.7K |
|
|
FLNT
3327
Fluent
FLNT
$49M
| $6.71M | ﹤0.01% |
451,240
-28
| -0% | -$417 |
|
3328
INNOVATE Corp
VATE
$67.3M
| $6.69M | ﹤0.01% |
276,620
-17,003
| -6% | -$411K |
|
3329
Galectin Therapeutics
GALT
$344M
| $6.68M | ﹤0.01% |
2,503,111
-11,271
| -0.4% | -$30.1K |
|
3330
Minerva Neurosciences
NERV
$15.2M
| $6.68M | ﹤0.01% |
262,598
-13,792
| -5% | -$351K |
|
3331
X4 Pharmaceuticals
XFOR
$73.2M
| $6.68M | ﹤0.01% |
32,873
+438
| +1% | +$89K |
|
3332
Intrepid Potash
IPI
$389M
| $6.67M | ﹤0.01% |
790,396
+7,459
| +1% | +$63K |
|
|
RESN
3333
DELISTED
Resonant Inc.
RESN
| $6.63M | ﹤0.01% |
2,786,391
-129,661
| -4% | -$309K |
|
|
FNHC
3334
DELISTED
FedNat Holding Company Common Stock
FNHC
| $6.63M | ﹤0.01% |
1,048,442
-8,998
| -0.9% | -$56.9K |
|
3335
Richmond Mutual Bancorp
RMBI
$140M
| $6.59M | ﹤0.01% |
622,603
-59,923
| -9% | -$634K |
|
|
CVLY
3336
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $6.57M | ﹤0.01% |
501,830
-5,374
| -1% | -$70.4K |
|
3337
BCB Bancorp
BCBP
$148M
| $6.56M | ﹤0.01% |
820,474
-1,019
| -0.1% | -$8.15K |
|
3338
Altimmune
ALT
$321M
| $6.56M | ﹤0.01% |
496,733
-84,547
| -15% | -$1.12M |
|
|
LOGC
3339
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $6.54M | ﹤0.01% |
719,959
+21,592
| +3% | +$196K |
|
3340
iShares ESG Optimized MSCI USA ETF
SUSA
$3.63B
| $6.53M | ﹤0.01% |
88,732
+15,376
| +21% | +$1.13M |
|
3341
Fennec Pharmaceuticals
FENC
$244M
| $6.51M | ﹤0.01% |
1,075,033
+5,772
| +0.5% | +$35K |
|
3342
OneWater Marine
ONEW
$261M
| $6.5M | ﹤0.01% |
317,095
-13,652
| -4% | -$280K |
|
3343
Ituran Location and Control
ITRN
$696M
| $6.49M | ﹤0.01% |
466,093
+14,090
| +3% | +$196K |
|
|
ZEPP
3344
Zepp Health
ZEPP
$727M
| $6.47M | ﹤0.01% |
125,941
+27,390
| +28% | +$1.41M |
|
3345
Global Water Resources
GWRS
$271M
| $6.47M | ﹤0.01% |
600,206
-3,946
| -0.7% | -$42.5K |
|
|
GRTS
3346
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $6.46M | ﹤0.01% |
2,438,958
-15,916
| -0.6% | -$42.2K |
|
|
NETI
3347
DELISTED
Eneti Inc.
NETI
| $6.44M | ﹤0.01% |
454,536
+145,773
| +47% | +$2.06M |
|
3348
Wrap Technologies
WRAP
$104M
| $6.43M | ﹤0.01% |
949,338
+225,733
| +31% | +$1.53M |
|
3349
First Business Financial Services
FBIZ
$431M
| $6.42M | ﹤0.01% |
449,111
-9,388
| -2% | -$134K |
|
3350
Genprex
GNPX
$9.76M
| $6.41M | ﹤0.01% |
47,688
+1,994
| +4% | +$268K |
|